EFFECTS OF VIBEGRON ON AMBULATORY BLOOD PRESSURE IN PATIENTS WITH OVERACTIVE BLADDER: RESULTS FROM A DOUBLE-BLIND STUDY

被引：0
|
作者：
Weber, Michael A.
White, William B.
King, Jennifer
Walker, Ann
Mudd, Paul N., Jr.
Haag-Molkenteller, Cornelia
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD66-11
引用
下载
收藏
页码：E1163 / E1163
页数：1
相关论文
共 50 条
  • [11] A DOUBLE-BLIND EVALUATION OF THE EFFECT OF AMLODIPINE ON AMBULATORY BLOOD-PRESSURE
    MROCZEK, WJ
    BURRIS, JF
    KLEIN, J
    POSTGRADUATE MEDICAL JOURNAL, 1991, 67 : S24 - S27
  • [12] Re: Vibegron, a Novel Potent and Selective β3-Adrenoreceptor Agonist, for the Treatment of Patients with Overactive Bladder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study
    Wein, Alan J.
    JOURNAL OF UROLOGY, 2019, 202 (02): : 218 - 218
  • [13] VIBEGRON DEMONSTRATES STATISTICALLY SIGNIFICANT IMPROVEMENT IN EFFICACY MEASURES IN OVERACTIVE BLADDER - KEY SECONDARY RESULTS FROM THE INTERNATIONAL PHASE 3 STUDY IN PATIENTS WITH OVERACTIVE BLADDER (EMPOWUR)
    Staskin, D.
    Frankel, J.
    Varano, S.
    Shortino, D.
    Jankowich, R.
    Mudd, P. N.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2019, 30 : S24 - S24
  • [14] EFFECTS OF CARBAMAZEPINE ON PATIENTS WITH PSYCHOMOTOR EPILEPSY - RESULTS OF A DOUBLE-BLIND STUDY
    RODIN, EA
    RIM, CS
    RENNICK, PM
    EPILEPSIA, 1974, 15 (04) : 547 - 561
  • [15] Randomized, double-blind study of controlled-release oxybutynin and tolterodine for overactive bladder in elderly patients.
    Anderson, RU
    Sieber, P
    Gottesman, JE
    Ritter, H
    Lama, DJ
    Zinner, N
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (04) : S144 - S144
  • [16] Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study
    Choo, M. -S.
    Lee, J. Z.
    Lee, J. B.
    Kim, Y. -H.
    Jung, H. C.
    Lee, K. -S.
    Kim, J. C.
    Seo, J. T.
    Paick, J. -S.
    Kim, H. -J.
    Na, Y. G.
    Lee, J. G.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (11) : 1675 - 1683
  • [17] Once-Daily Vibegron 75 mg for Overactive Bladder: Long-Term Safety and Efficacy from a Double-Blind Extension Study of the International Phase 3 Trial (EMPOWUR)
    Staskin, David
    Frankel, Jeffrey
    Varano, Susann
    Shortino, Denise
    Jankowich, Rachael
    Mudd, Paul N., Jr.
    JOURNAL OF UROLOGY, 2021, 205 (05): : 1421 - 1428
  • [18] DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF THE ANTIHYPERTENSIVE EFFICACY OF NITRENDIPINE IN PATIENTS SUBMITTED TO AMBULATORY BLOOD-PRESSURE MONITORING
    HONORATO, J
    AZANZA, J
    GUINDO, N
    SUAREZ, JR
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1989, 46 (05): : 932 - 939
  • [19] A randomised, prospective double-blind, propiverine-controlled trial of imidafenacin in patients with overactive bladder
    Park, C.
    Park, J.
    Choo, M-S
    Kim, J. C.
    Lee, J. G.
    Lee, J. Z.
    Lee, K-S
    Kim, D. Y.
    Lee, S-J
    Seo, J. T.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (02) : 188 - 196
  • [20] Plain language summary of safety and symptom improvement with vibegron in people with overactive bladder: results from the EMPOWUR study
    Staskin, David
    Frankel, Jeffrey
    Gregg, Steven G.
    Varano, Susann
    Owens-Grillo, Janet
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2023, 12 (09)
12345